Single-Cell Omics Market Report 2026

Single-Cell Omics Market Overview

• Single-Cell Omics market size has reached to $2.39 billion in 2025 • Expected to grow to $5.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.4% • Growth Driver: Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market • Market Trend: Advanced Kits For Single-Cell Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-Cell Omics Market?

Single-cell omics refers to the profile of single cells taken from heterogeneous populations of cells in various cellular stages, allowing for the study and dissection of both healthy development and disease processes at the single-cell level. Single-cell omics are used for the molecular analysis of cellular heterogeneity, cell type identification, illness research, and the creation of therapeutics. The main types of single-cell omics products are single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Single-cell genomics is a sophisticated technique for categorizing individual cells that can recognize unusual cell types and explain distinctive traits. The various technologies are cell isolation technologies, sample preparation technologies, and analysis of next-generation sequencing applied in oncology, cell biology, neurology, and immunology. The end users are pharmaceutical and biotechnology companies, academic and research organizations, hospital and diagnostic laboratories, and others.

What Is The Single-Cell Omics Market Growth Forecast?

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $5.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to expansion of precision medicine programs, integration of AI in omics analysis, increasing pharmaceutical R&D investments, rising adoption in clinical diagnostics, development of cost-effective single-cell platforms. Major trends in the forecast period include rising adoption of multi-omics approaches, growing demand for high-resolution cellular analysis, expansion of single-cell applications in oncology research, increased use of microfluidics for cell isolation, standardization of single-cell analysis workflows.

Global Single-Cell Omics Market Segmentation

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics 2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing 3) By Application: Oncology, Cell Biology, Neurology, Immunology 4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users Subsegments: 1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits 2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits 3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits 4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Is The Driver Of The Single-Cell Omics Market?

The rising prevalence of cancer is expected to propel the growth of the single-cell omics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Identifying biomarkers for cancer diagnosis, prognosis prediction, and discovering novel therapeutic targets in predetermined clinical cohorts has made substantial use of single-cell omics data. For instance, in May 2024, according to the National Institutes of Health, a US-based government agency, as of January 2022, approximately 18.1 million individuals in the United States were living as cancer survivors. This number is expected to rise to 22.5 million by 2032. Therefore, the rising prevalence of cancer is driving the growth of the single-cell omics industry.

Key Players In The Global Single-Cell Omics Market

Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

Global Single-Cell Omics Market Trends and Insights

Major companies in the single-cell omics market are focused on developing advanced kits, such as sequencing kits, for single-cell applications and to drive their revenues in the market. Sequencing kits are pre-packaged sets of reagents and materials designed for genetic sequencing processes, facilitating streamlined laboratory workflows. For instance, in February 2023, Singular Genomics Systems, Inc., a US-based company leveraging novel next-generation sequencing (NGS), launched the Max Read Kits for single-cell sequencing on the G4 Sequencing Platform. The Max Read Kits are designed for compatibility with popular 10x Genomics assays and allow flexibility for sequencing 4 to 16 samples per run. The kits provide 800 million reads per flow cell with 80% to 90% Q30 quality. Singular Genomics also enhances the quality specifications of the G4 Sequencing Platform's F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for select applications.

What Are Latest Mergers And Acquisitions In The Single-Cell Omics Market?

In August 2025, 10x Genomics, a US-based provider of single-cell and spatial biology instruments, consumables, and software, acquired Scale Biosciences for $13.5 million. Through this acquisition, 10x Genomics aims to enhance its Chromium platform by integrating Scale’s scalable single-cell technologies, thereby advancing high-throughput single-cell analysis and making it more powerful, affordable, and accessible. Scale Biosciences is a US-based company specializing in providing single-cell omics solutions.

Regional Insights

North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Single-Cell Omics Market?

The single-cell omics market includes revenues earned by entities through single-cell sorting and isolation, single-cell sample preparation kits, and related single-cell data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Single-Cell Omics Market Report 2026?

The single-cell omics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell omics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.